Soleno Therapeutics (SLNO) EPS (Basic) Growth (3y) (2016 - 2026)
Soleno Therapeutics (SLNO) EPS (Basic) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 37.73% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 14.29% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -2.89% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 137.22% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | 38.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.76% |
| Dec 31, 2025 | 28.36% |
| Sep 30, 2025 | -26.34% |
| Jun 30, 2025 | -56.96% |
| Mar 31, 2025 | 6.68% |
| Dec 31, 2024 | 48.60% |
| Sep 30, 2024 | -38.35% |
| Jun 30, 2024 | -2.67% |
| Mar 31, 2024 | -17.05% |
| Dec 31, 2023 | 28.47% |
| Sep 30, 2023 | -44.97% |
| Jun 30, 2023 | 40.49% |
| Mar 31, 2023 | 35.94% |
| Dec 31, 2021 | -378.94% |
| Sep 30, 2021 | -73.73% |
| Jun 30, 2021 | -91.80% |
| Mar 31, 2021 | -63.43% |
| Dec 31, 2020 | 30.41% |
| Sep 30, 2020 | -79.26% |
| Jun 30, 2020 | -44.06% |